Perinatal, cardiovascular and sleep-related diseases are major health problems, and are on the rise. Detecting these diseases at an early stage is critical to halt this rise, to prevent comorbidities, and to lower healthcare costs while simultaneously improving patient quality of life. The MEDUSA project proposed here seeks to leverage technological advances in pathophysiological modeling, unobtrusive sensing, monitoring and data analysis to enable earlier recognition, mitigate progression and improve treatment of perinatal, cardiovascular and sleep-related diseases. The project covers several pregnancy complications (such as preeclampsia and fetal asphyxia), several cardiovascular diseases and conditions (heart failure, atrial fibrillation, peripheral arterial obstructive disease, coronary artery disease), and obstructive sleep apnea. Cardiorespiratory risk factors are a common denominator of most of these complications and diseases, and accordingly technologies for assessment of these risk factors figure prominently throughout the project. The general approach in MEDUSA is to co-develop novel technological solutions in a controlled clinical environment, and to subsequently refine and validate them in extramural and at-home settings, immediately followed by deployment in the healthcare system with the aim to increase effectiveness at lower costs in combination with lower patient burden and higher patient quality of life.
|Short title||20.0295/PPS2006 ID|
|Effective start/end date||1/01/21 → 31/12/25|
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.